AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. WAKAMOTO PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Pretax margin (%)

WAKAMOTO PHARMACEUTICAL CO.,LTD.【JP:4512】

Market cap
¥11B
P/E ratio
54.7x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndPretax margin (%) YoY (%)
Mar 31, 2025-5.3+151.18%
Mar 31, 2024-2.1-174.67%
Mar 31, 20232.8+224.95%
Mar 31, 20220.9-112.67%
Mar 31, 2021-6.8-18.51%
Mar 31, 2020-8.3+119.05%
Mar 31, 2019-3.8+416.88%
Mar 31, 2018-0.7-177.55%
Mar 31, 20171-14.90%
Mar 31, 20161.1-48.69%
Mar 31, 20152.2-39.62%
Mar 31, 20143.6+101.73%
Mar 31, 20131.8-168.72%
Mar 31, 2012-2.6

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)